UK and Ireland Neuroendocrine Tumour Society
3 May 2017
It is a great honour to have been invited to take on the Chair of the NCRI NET sub-group. Under […]
Read More about Prof Tim Meyer is new Chair of NCRI NET sub-group
3 May 2017
With the support of a one year pilot grant from NETRF, Tim Meyer established a collaborative group at UCL to […]
Read More about Defining the Immune Landscape in Neuroendocrine Tumours
3 May 2017
Where do you go to when you want to remind yourself of the salient practice issues for managing NETs? ENETS, […]
3 May 2017
A scientific collaboration between UCL, Dana-Farber Cancer Institute, UCSF Medical Centre and the UCL Cancer Institute / Royal Free Hospital […]
Read More about International team receive $1.2 million boost for NET research
3 May 2017
The UKINETs Research Committee are currently setting up a Neuroendocrine tumour domain of the Genomics England Clinical Interpretation Partnership (GeCIP). GeCIPs […]
Read More about NET Genomics England Clinical Interpretation Partnership (GeCIP) subgroup
1 May 2017
4th World Congress on Theranostics Melbourne, November 2016 The theme of the most recent World Congress (a bi-annual meeting to […]
Read More about Update from the 4th World Congress on Theranostics
19 April 2017
UKINETS Chair, Prof John Ramage, is fundraising for the NET Patient Foundation and King’s College Hospital Charity, along with three friends. Please […]
13 April 2017
A one-day course for trainees and consultants wishing to gain confidence in the investigation and management of patients with neuroendocrine […]
27 February 2017
The 15th National Conference will take place on the 4 December 2017 at the Royal College of Physicians, London. This […]
Read More about 15th National UKINETS Conference – Save the Date!
20 February 2017
Save the date – Monday 2nd October 2017 – Prospero House, London Join us for this annual meeting which brings […]
7 February 2017
Our first newsletter of 2017 is available to view here…
30 January 2017
Ever since my move from London to Cardiff just over 2 years ago, we have been working with patient groups […]
